Immuneering-logo (1).png
Immuneering Announces Positive Initial Phase 1 Pharmacokinetic, Pharmacodynamic and Safety Data for IMM-1-104 Universal-RAS Program; Accelerates Study Timeline
April 18, 2023 09:00 ET | Immuneering Corporation
Data presented at AACR Annual Meeting support IMM-1-104's potential to address a broad population of patients with RAS mutant tumorsIMM-1-104 well tolerated with no dose limiting toxicities (DLTs) or...
catapult logo.png
Catapult Learning Selected by Mississippi Department of Education to Provide Statewide Professional Development and Coaching Services
February 08, 2023 08:15 ET | Catapult Learning
PHILADELPHIA, Feb. 08, 2023 (GLOBE NEWSWIRE) -- Catapult Learning, a provider of intervention programs for students and professional development solutions for teachers in K-12 schools, announced its...
2 Day Virtual Credit Risk Measurement and Management Course: October 17-18, 2022
October 03, 2022 04:03 ET | Research and Markets
Dublin, Oct. 03, 2022 (GLOBE NEWSWIRE) -- The "Credit Risk Measurement and Management" training has been added to's offering. The course will give you detailed knowledge of...
Logo 1.png
Aeterna Zentaris Announces Shareholder Approval of Share Consolidation
July 15, 2022 16:15 ET | Aeterna Zentaris Inc
TORONTO, ONTARIO, July 15, 2022 (GLOBE NEWSWIRE) -- Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS) ("Aeterna" or the "Company"), a specialty biopharmaceutical company developing and...
Logo 1.png
Aeterna Zentaris Announces Results of Annual Meeting of Shareholders
June 21, 2022 16:01 ET | Aeterna Zentaris Inc
- Vote to approve share consolidation adjourned to July 6, 2022 TORONTO, ONTARIO, June 21, 2022 (GLOBE NEWSWIRE) -- Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS) ("Aeterna" or the "Company"), a...
Straits Research Pvt Ltd
Neurodegenerative Diseases Market to reach USD 53 Billion by 2030 and grow steadily at a CAGR of 3.2%: Straits Research
May 27, 2022 11:30 ET | Straits Research
New York, United States, May 27, 2022 (GLOBE NEWSWIRE) -- Neurodegenerative diseases are a large and diverse group of disorders characterized by progressive deterioration of the function and...
Logo 1.png
Aeterna Zentaris to Present at the H.C. Wainwright Global Investment Conference
May 18, 2022 08:00 ET | Aeterna Zentaris Inc
TORONTO, ONTARIO, May 18, 2022 (GLOBE NEWSWIRE) -- Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS) (“Aeterna” or the “Company”), a specialty biopharmaceutical company developing and commercializing...
RespireRx Pharmaceuticals Inc. Announces Patent Filings Claiming Novel Lipid Based Formulations for Insoluble Compounds, Including Cannabinoids Such as Dronabinol
March 23, 2022 08:00 ET | RespireRX Pharmaceuticals Inc.
Glen Rock, N.J., March 23, 2022 (GLOBE NEWSWIRE) -- RespireRx Pharmaceuticals Inc. (OTCQ:RSPI) (“RespireRx” or the “Company”), a leader in the discovery and development of innovative and...
Oncotelic Presenting at BiotechGate Digital Partnering
February 24, 2022 08:01 ET | Oncotelic Therapeutics, Inc.
OT-101 is Oncotelic’s RNA Therapeutic Against TGF-βOT-101 has completed over six clinical trials against solid tumors with good efficacyOT-101 is currently undergoing a phase 1b trial in combination...
Capital Market Laboratories (CMLviz) Speaks With PagerDuty (PD) CFO – Measuring What Matters
September 16, 2021 11:02 ET | Capital Market Laboratories
LOS ANGELES, Sept. 16, 2021 (GLOBE NEWSWIRE) -- In a conversation with Capital Market Laboratories (CMLviz), Chief Financial Officer of PagerDuty Howard Wilson had clear messages: The company is...